Thromb Haemost 2001; 86(04): 1127-1128
DOI: 10.1055/s-0037-1616551
Letters to the Editor
Schattauer GmbH

Comparison of a Test for Soluble Fibrin Polymer (TpPTM) with a Standard Quantitative ELISA for D-dimer in Patients, without Current Thrombosis, who Have Cancer or Renal Disease

Yale S. Arkel
1   Maine Medical Center, Research Institute, Scarborough, Maine, USA
,
De-Hui W. Ku
1   Maine Medical Center, Research Institute, Scarborough, Maine, USA
,
Phuong Le
1   Maine Medical Center, Research Institute, Scarborough, Maine, USA
,
Ann Marie Carr
1   Maine Medical Center, Research Institute, Scarborough, Maine, USA
› Author Affiliations
Further Information

Publication History

Received 05 April 2001

Accepted 16 May 2001

Publication Date:
09 December 2017 (online)

 

 
  • References

  • 1 LaCapra S, Arkel YS, Ku DH, Gibson D, Lake C, Lam X. The use of thrombus precursor protein, D-dimer, prothrombin fragment 1.2, and thrombin antithrombin in the exclusion of proximal deep vein thrombosis and pulmonary embolism. Blood Coagul Fibrinolysis 2000; 11: 371-377.
  • 2 Bates SM, Grand’Maison A, Johnston M, McGrath J, Ginsberg JS. Use of the thrombus precursor protein (TpP) to exclude deep vein thrombosis [abstract]. Thromb Haemost 1999; 82 (Suppl. 01) 259.
  • 3 Janssen MCH, Heebels AE, de Metz M, Verbruggen H, Wollersheim H, Janssen S, Schuurmans MMJ, Nováková IRO. Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep venous thrombosis. Thromb Haemost 1997; 77: 262-6.
  • 4 Bounameaux H, de Moerloose P, Perrier A, Reber G. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 1994; 104: 134-44.
  • 5 van der Graaf F, van den Borne H, van der Kolk M, de Wild PJ, Janssen GWT, van Uum SHM. Exclusion of deep venous thrombosis with D-dimer testing: comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard. Thromb Haemost 2000; 83: 191-8.
  • 6 Gouin Thibault I, Samama MM. Laboratory diagnosis of the thrombophilic state in cancer patients. Semin Thromb Hemost 1999; 25: 167-72.
  • 7 Gaffney PJ, Creighton LJ, Callus MJ, Thorpe R. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II Evolution in a variety of clinical conditions. Br J Haematol 1988; 68: 91-6.
  • 8 Ghirardini G, Battioni M, Bertellini C, Colombini R, Colla R, Rossi G. D-dimer after delivery in uncomplicated pregnancies. Clin Exp Obstet Gynecol 1999; 26: 211-2.